NextPoint Therapeutics, Inc.
Industry: Biotechnology (See others in industry)
Address:
238 Main Street
Cambridge, MA, 02142
Phone: 508-204-1115
Cambridge, MA, 02142
Phone: 508-204-1115
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-30 | New | $33,728,772 | $33,728,772 | Equity Only | 06b | SEC link |
| 2024-02-14 | New | $42,479,388 | $42,479,388 | Equity Only | 06b | SEC link |
| 2022-12-27 | New | $79,999,992 | $79,999,992 | Equity Only | 06b | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Detlev Biniszkiewicz | Director |
| Ivan Cheung | Director, Executive |
| Paul Conrad | Executive |
| Rakhshita Dhar | Director |
| Ansbert Gadicke | Director |
| Paulina Hill | Director |
| Axel Hoos | Director |
| Jeffrey Lacey | Executive |
| Matthew Roden | Director |
| Matthew Roden) | Director |
| Brian Shuster | Director |
| R. Jacob Vogelstein | Director |